Blood‐based biomarkers for Alzheimer's disease

Neurodegenerative disorders such as Alzheimer's disease (AD) represent a mounting public health challenge. As these diseases are difficult to diagnose clinically, biomarkers of underlying pathophysiology are playing an ever‐increasing role in research, clinical trials, and in the clinical work‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Leuzy, Antoine, Mattsson‐Carlgren, Niklas, Palmqvist, Sebastian, Janelidze, Shorena, Dage, Jeffrey L, Hansson, Oskar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749476/
https://www.ncbi.nlm.nih.gov/pubmed/34859598
http://dx.doi.org/10.15252/emmm.202114408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749476/
https://www.ncbi.nlm.nih.gov/pubmed/34859598
http://dx.doi.org/10.15252/emmm.202114408

Ejemplares similares